Madenco Biosciences Creates New Line of Cosmeceuticals to Complement Bellus Skin™ Serum for Anti-Aging

EDMONTON, ALBERTA – Madenco Biosciences Inc., a subsidiary of Quest PharmaTech Inc., focused on bringing clinically validated products to the consumer and dermatology market by utilizing proprietary transdermal delivery technologies, announced today that they have created the SP-DERM line of cosmeceuticals specifically targeting applications that are demanded by dermatologists and medi-spas.

Read press release details.

This site has features Features include this sites' Hover Navigation; Carousel; Gallery; Cart; and Checkout. that require Javascript Javascript is a web browser technology that adds advanced behaviour to websites in order to make them more rich and interactive. Please note Java is different and is not required. . Please follow these instructions to enable it in your browser.